New Jersey Gets Personalized – A series of initiatives from BioNJ to advance the Diagnostics industry and foster partnerships with biopharma companies in the State of New Jersey. How New Technologies are Changing Opportunities in the Diagnostics Industry, Creating Value and Encouraging Partnerships  

BioNJ Thanks Special Guest G. Steven Burrill for his continued vision, expertise, and leadership in the diagnostics industry and the development of personalized medicine. 

CLICK HERE to view the presentation by G. Steven Burrill. 
CLICK HERE or on the slide above to view the Webinar in its entirety.

Special Guest: G. Steven Burrill, Chief Executive Officer, Burrill & Company
    

Dear Life Sciences Colleagues,  

Thank you for attending the Diagnostics Webinar. This online event explored the Diagnostics industry, its evolving trends, and changing opportunities with the emergence of personalized medicine.  Webinar special guest G. Steven Burrill, Chief Executive Officer, Burrill & Company, provided a unique overview of the Diagnostics industry, its past and future, and how technology is changing both the opportunities and the value proposition for life science companies.  

This event represented a rare opportunity to learn from the unique perspective of our guest speaker on how the emergence of personalized medicine is creating new opportunities for companies to partner, innovate and transform the value of drug development and treatment outcomes.  

A poll was conducted during the webinar; results will be published in an upcoming issue of BioLines, BioNJ’s E-Letter.